Method for Constructing Human iPS Cell Line RZPBi001 from Peripheral Blood Cells

Journal Title: Journal of Clinical & Cellular Immunology - Year 2023, Vol 14, Issue 3

Abstract

Patient-derived hiPSCs could generate indefinitely illness-related cells and organoids, allowing research scientist to reproduce some pathologic change of human sickness models in petri dishes. Whereas, dermal fibroblasts require some traumatic injury to obtain and have the risky of accumulating variations due to unveil to external stimulus such as UV light. Meanwhile, peripheral blood is regarded to be a more excellent source of somatopiasm because it is less damage to collect and its mutation load is significantly lower than that of skin tissue. In this paper, we describe the successful construction of non-integration hiPSCs form human peripheral blood cells by Sendai virus. A healthy adult female of Han nationality from China contributed her Peripheral Blood Mononuclear Cells (PBMCs). Non-integrating Sendai virus recombinant PBMCs with human OSKM (Oct4, Sox2, Kl4 and c-Myc) transcription factors. The pluripotency of transgenic-free iPSCs was confirmed by immunofluorescence staining of pluripotency markers and the capacity of iPSCs to initially differentiate into 3 germ layers in vitro. Moreover, iPSC lines demonstrated awfully normal karyotypes. In the research of illness progression and pathogenesis (eg, DMD, SMA, ALS), iPSC lines can be used as controls.

Authors and Affiliations

Xiaoqing Chen Yuling Lua Rong Ying Weiming Yua Pengfei Tian Dongming Hua Yu Feng

Keywords

Related Articles

Hyper IgM Syndromes: A Brief Review of the Pathogenesis, Clinical Features and Management

Primary Immuno Deficiency (PID) disorders are heterogeneous disorders of the innate or the adaptive immune system, leading to recurrent infections that can also predispose to autoimmune diseases and malignancies. Hyper I...

Exercise-Mediated Immune Protection in Chronic Kidney Disease Decreases Infection and Severe Evolution of COVID-19

It is constantly sought to understand the different mechanisms of action of the immune system to establish potential efficient therapeutic targets for different clinical situations. Thus, the present study aims to expand...

Secretory IgA and Course of COVID-19 in Patients Receiving a BacteriaBased Immunostimulant Agent in Addition to Background Therapy

Background: Mucosal immunity plays a major role not only in the prevention but probably also in the outcome of COVID-19. An enhanced production of secretory Immunoglobulin A (sIgA) might contribute to the activation of t...

Method for Constructing Human iPS Cell Line RZPBi001 from Peripheral Blood Cells

Patient-derived hiPSCs could generate indefinitely illness-related cells and organoids, allowing research scientist to reproduce some pathologic change of human sickness models in petri dishes. Whereas, dermal fibroblast...

Diagnostic Challenges and Immunological Barriers in Kidney Transplantation

The presence of donor specific antibodies and HLA-incompatibility between waiting list patients and potential donors make transplantation programs worldwide complicated and stand as a major barrier for a quick access for...

Download PDF file
  • EP ID EP741781
  • DOI 10.35248/2155-9899.23.14.686.
  • Views 29
  • Downloads 0

How To Cite

Xiaoqing Chen Yuling Lua Rong Ying Weiming Yua Pengfei Tian Dongming Hua Yu Feng (2023). Method for Constructing Human iPS Cell Line RZPBi001 from Peripheral Blood Cells. Journal of Clinical & Cellular Immunology, 14(3), -. https://europub.co.uk/articles/-A-741781